Qinglong Guo Selected Research

Inflammation (Inflammations)

10/2019	The involvement of lipid raft pathway in suppression of TGFβ-mediated metastasis by tolfenamic acid in hepatocellular carcinoma cells.
1/2017	Baicalein reduces angiogenesis in the inflammatory microenvironment via inhibiting the expression of AP-1.
9/2016	LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling.
6/2016	Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway.
1/2016	LFG-500, a newly synthesized flavonoid, attenuates lipopolysaccharide-induced acute lung injury and inflammation in mice.
6/2015	Lactate promotes PGE2 synthesis and gluconeogenesis in monocytes to benefit the growth of inflammation-associated colorectal tumor.
1/2015	LZ-207, a Newly Synthesized Flavonoid, Induces Apoptosis and Suppresses Inflammation-Related Colon Cancer by Inhibiting the NF-κB Signaling Pathway.
8/2013	Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6/STAT3 signaling pathway.
1/2012	Oroxylin A, a classical natural product, shows a novel inhibitory effect on angiogenesis induced by lipopolysaccharide.
11/2011	XJP-1, a novel ACEI, with anti-inflammatory properties in HUVECs.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qinglong Guo Research Topics

Disease

113	Neoplasms (Cancer) 05/2024 - 08/2006
30	Breast Neoplasms (Breast Cancer) 02/2023 - 08/2008
24	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 08/2006
14	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2008
13	Hypoxia (Hypoxemia) 10/2022 - 09/2013
11	Leukemia 10/2021 - 01/2012
11	Inflammation (Inflammations) 10/2019 - 05/2009
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 05/2013
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 08/2014
8	Carcinoma (Carcinomatosis) 10/2020 - 03/2008
8	Colitis 01/2019 - 08/2013
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 08/2008
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 08/2013
6	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 06/2011
6	Colonic Neoplasms (Colon Cancer) 01/2017 - 01/2015
5	Glioma (Gliomas) 10/2022 - 10/2013
5	Carcinogenesis 10/2021 - 08/2013
5	Body Weight (Weight, Body) 06/2021 - 09/2011
4	Lung Neoplasms (Lung Cancer) 05/2024 - 03/2008
4	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022 - 11/2014
4	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 01/2012
3	Prostatic Neoplasms (Prostate Cancer) 02/2023 - 09/2020
3	Infections 02/2022 - 09/2011
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 03/2016
3	Liver Diseases (Liver Disease) 08/2020 - 08/2012
3	Colitis-Associated Neoplasms 01/2017 - 08/2013
2	Tuberculosis (Tuberculoses) 10/2022 - 01/2022
2	Pulmonary Tuberculosis 03/2022 - 01/2020
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 11/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2019 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 11/2018 - 06/2017
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 06/2018 - 04/2018
2	Disease Progression 01/2018 - 08/2014
2	Liver Neoplasms (Liver Cancer) 01/2018 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2017 - 01/2017

Drug/Important Bio-Agent (IBA)

44	FlavonoidsIBA 10/2023 - 05/2009
37	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 10/2023 - 01/2009
35	wogoninIBA 11/2022 - 08/2006
16	Proteins (Proteins, Gene)FDA Link 05/2024 - 10/2008
15	gambogic acidIBA 04/2017 - 10/2008
10	wogonosideIBA 10/2019 - 05/2009
6	Phosphotransferases (Kinase)IBA 10/2023 - 10/2013
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 06/2009
6	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 08/2006
5	InflammasomesIBA 10/2023 - 03/2015
5	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2023 - 08/2014
5	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 12/2008
5	Messenger RNA (mRNA)IBA 01/2022 - 12/2011
5	baicaleinIBA 08/2020 - 01/2010
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 06/2013
5	Dextran SulfateIBA 09/2016 - 03/2015
4	Therapeutic UsesIBA 12/2023 - 01/2022
4	Imatinib Mesylate (Gleevec)FDA Link 09/2020 - 04/2016
4	oroxylin A-7-O-glucuronideIBA 08/2020 - 04/2016
4	LYG 202IBA 01/2018 - 01/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 09/2013
4	PiperazineIBA 01/2018 - 01/2009
4	CateninsIBA 11/2016 - 10/2013
4	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2011 - 08/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 03/2008
3	Aldo-Keto ReductasesIBA 02/2023 - 08/2022
3	Hormones (Hormone)IBA 02/2023 - 10/2020
3	EnzymesIBA 02/2023 - 06/2015
3	CholesterolIBA 01/2022 - 12/2011
3	Transcription Factors (Transcription Factor)IBA 11/2020 - 08/2014
3	CytokinesIBA 01/2019 - 08/2013
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 05/2015
3	LFG-500IBA 06/2017 - 01/2014
3	Interleukin-6 (Interleukin 6)IBA 06/2016 - 08/2013
3	Annexin A5IBA 03/2014 - 11/2008
3	xanthoneIBA 11/2012 - 12/2011
2	ThioredoxinsIBA 05/2024 - 05/2015
2	AnthracyclinesIBA 02/2023 - 01/2023
2	AcidsIBA 01/2023 - 06/2021
2	LipidsIBA 11/2022 - 10/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 01/2017
2	Indicators and Reagents (Reagents)IBA 02/2022 - 08/2012
2	RNA (Ribonucleic Acid)IBA 02/2022 - 01/2022
2	Pyruvic Acid (Pyruvate)IBA 01/2022 - 06/2015
2	Cyclin-Dependent Kinase 9IBA 01/2022 - 01/2021
2	NucleotidesIBA 01/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2014
2	Hypoxia-Inducible Factor 1IBA 11/2020 - 06/2015
2	Histone Deacetylase InhibitorsIBA 10/2020 - 08/2020
2	Thomsen-Friedenreich antibodiesIBA 01/2020 - 12/2019
2	GlycolipidsIBA 01/2020 - 01/2018
2	artemisinin (artemisinine)IBA 11/2019 - 11/2018
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2019 - 04/2011
2	TNF Receptor-Associated Factor 2 (TRAF2)IBA 10/2019 - 01/2017
2	matrigelIBA 01/2018 - 12/2008
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2017 - 09/2016
2	NF-E2-Related Factor 2IBA 01/2017 - 11/2014
2	AzoxymethaneIBA 06/2016 - 08/2013
2	LipopolysaccharidesIBA 01/2016 - 11/2011
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 06/2015 - 09/2013

Therapy/Procedure

20	Therapeutics 12/2023 - 06/2009
9	Drug Therapy (Chemotherapy) 02/2023 - 01/2012
4	Intravenous Injections 08/2014 - 03/2008
3	Oral Administration 06/2021 - 01/2010
2	Photothermal Therapy 12/2023 - 10/2022